Canopy Growth To Ring Nasdaq Opening Bell

Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced that chief executive officer David Klein and other Canopy Growth team members will ring the Nasdaq opening bell on December 12, 2022.

Canopy Growth Corporation (NASDAQ:CGC) (TSX:WEED) announced that chief executive officer David Klein and other Canopy Growth team members will ring the Nasdaq opening bell on December 12, 2022.

“We are proud to be a Nasdaq-listed company, and our team is honored to be ringing the opening bell. This is an exciting time for Canopy Growth as we take important steps to realize our goal of building a leading North American cannabis company. We appreciate the continued support of all of our stakeholders as we take ambitious strides towards unleashing the power of cannabis,” stated Klein.

The opening bell ceremony will be broadcast live starting at 9:15 a.m. Eastern Time from the Nasdaq MarketSite Tower in New York City, New York.

Price Action

Canopy Growth shares were trading 0.65% lower at $3.07 per share, during Friday’s pre-market session.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Tim Foster on Unsplash

Related News

Aurora Cannabis: What Makes Upside Potential For This Pot Stock? Analyst Has An Idea

Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results

Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral

Total
0
Shares
Related Posts
Read More

$1.8M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed lower on Thursday, after recording gains for 13 straight sessions in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ICCT

Read More

Molecular Instruments Announced The Patents Court Of England And Wales Has Ordered That Two Patents Owned By Advanced Cell Diagnostics, A Bio-Techne Company, Both Be Revoked, Advanced Cell Diagnostics’ Infringement Claims Against Molecular Instruments…

Molecular Instruments, Inc. announced that the Patents Court of the High Court of England and Wales has ordered: (1) that two patents owned by Advanced Cell Diagnostics, Inc. ((a Bio-Techne group company, NASDAQ:TECH)

TECH